Traduction de «where » (Français → Néerlandais) :

There was no difference in effect in trials where the dose was tapered or weaned off, compared to those where withdrawal was abrupt.
There may be a small benefit from higher dosed patches than in lower dosed patches.

The results of these trials are concordant with previous trials, except one where Bupropion was evaluated in an unmotivated population.
The results of these trials are concordant with previous trials, except one where bupropion was evaluated in an unmotivated population.

Only 26% would choose to inform the patient outside the existing organs, and with a stronger preference on informing after the decision is taken. In the first scenario, there is no significant difference between the respondents with regard to the choice of the place where the information is given (inside or outside the existing decision-making organs) according their current/past membership (or not) of the INAMI – RIZIV organs.
In the first scenario, there is no significant difference between the respondents with regard to the choice of the place where the information is given (inside or outside the existing decision-making organs) according their current/past membership (or not) of the INAMI – RIZIV organs.

Slideshow : Where and how can ethics be part of HTA?
Slideshow : Where and how can ethics be part of HTA?

„They are designed to help practitioners assimilate, evaluate and implement the everincreasing amount of evidence and opinion on best current practice. Clinical guidelines are intended as neither cookbook nor textbook but, where there is evidence of variation in practice which affects patient outcomes and a strong research base providing evidence of effective practice, guidelines can assist doctors and other health care professionals in making decisions about appropriate and effective care for their patients.
variation in practice which affects patient outcomes and a strong research base providing evidence of effective practice, guidelines can assist doctors and other health care professionals in making decisions about appropriate and effective care for their patients.

− Armand M. Lipases and lipolysis in the human digestive tract: where do we stand?
Armand M. Lipases and lipolysis in the human digestive tract: where do we stand?

Additionally, Pfizer announced that it has signed a lease for laboratory space at the Center for Life Science in the Longwood Medical Area, where it will co-locate with its academic medical center partners.
“We are thrilled that Pfizer has chosen Boston as the location for its newest Center for Therapeutic Innovation -- which will also serve as the program’s world headquarters,” said Mass.

This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.